GENVAULT CORP

Profile

Company Names

GENVAULT CORP

Addresses

6190 CORTE DEL CEDRO, CARLSBAD, CA 92011

Phone Numbers

760.268.5200

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$6,801,794.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2009-11-13 
$6,801,794.00 
$6,837,018.00 
$35,224.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JAMES 
C. 
BLAIR, PH.D. 
DIRECTOR
MERITAGE PHARMA INC   |  GENVAULT CORP
WILLIAM 
R. 
BRODY, M.D., PH.D. 
DIRECTOR
GENVAULT CORP
JAY 
 
FLATLEY 
DIRECTOR
HELIXIS INC   |  GENVAULT CORP   |  HELIX HOLDINGS I, LLC   |  JUNO THERAPEUTICS, INC.   |  IRIDIA, INC.   |  CELLANOME, INC.
ERIK 
 
HOLMLIN 
EXECUTIVE OFFICER
GENVAULT CORP   |  APPLIED PROTEOMICS, INC.   |  NANOSPHERE INC
PAUL 
J. 
MIRABELLA 
DIRECTOR
NAVISCAN PET SYSTEMS INC   |  NAVISCAN, INC   |  GENVAULT CORP
BENJAMIN 
S. 
SCHAPIRO 
DIRECTOR
GENVAULT CORP   |  ANGIOSCORE INC.   |  COURION CORP   |  INTEGENX INC   |  QUESTMARK PARTNERS IV, L.P.
JOHN 
 
SPILMAN 
DIRECTOR
GENVAULT CORP   |  BREATHE TECHNOLOGIES, INC.   |  RPLUS ENERGIES FRONTIER, LLC
DAVID 
 
WELLIS, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
GENVAULT CORP   |  COMMUNITY BIO, INC.   |  EXCELLOS, INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2010-11-24
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2009-11-13 
2010-09-30
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2009-11-13 
2010-06-15
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2009-11-13 
2009-11-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2009-11-13 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#